HCPCS code Q5160 — Inj, jobevne, 10 mg. Status: Active. Effective Jan 1, 2026. Source: CMS HCPCS Level II.

Q5160

Active

Inj, jobevne, 10 mg

Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2026
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0918

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2026-Q1
    Inj, jobevne, 10 mg